As reported in a research article, five patients had a valve-in-valve performed to replace a trifecta valve due to stenosis, regurgitation, and high gradient.The results of the investigation are inconclusive since a valve-in-valve was performed and the device was not accessible for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
|
It was reported through a research article identifying trifecta that may be related to a valve in valve procedure.Specific patient information is documented as unknown.Details are listed in the article, titled [valve-in-valve implantation using the acurate neo in degenerated aortic bioprostheses].It was reported from the study that 85 patients from 14 centers in europe and (b)(6) were implanted with a variety of make and model of tissue heart valves.Five of the patients were originally implanted with a trifecta valve.After a median time of 9.2 years (range 1.1 to 18.1 years), stenosis, regurgitation, and high gradient were observed and the patients were treated with valve in valve procedure using the acurate neo.The major complications for the 30-day outcomes were reported to be vascular complication (5%), bleeding (5%), kidney injury (2%), permanent pacemaker implantation (1%), left bundle branch block (2%), new onset atrial fibrillation (2%), and stroke (1%).
|